Healthy Extracts Secures $555,556 Convertible Note From Hinterland Partners

Healthy Extracts (HYEX) secured a $555,556 convertible note from Hinterland Partners, receiving $459,500 net. The 30-month note has 13% annual interest, monthly revenue-based payments starting March 2027, and a $2.00 conversion price. The company pledged its assets as collateral, with the agreement terminating upon a Nasdaq, NYSE, or NYSE American listing.

Original reporting
Published Nov 17, 2026, 11:03 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 11:13 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Healthy Extracts Secures $555,556 Convertible Note From Hinterland Partners — source image
Decision brief

The 30-second read

$HYEXBearishMed
01

Why it matters

Traders should assess HYEX’s credit risk (secured collateral), equity dilution risk (conversion at $2.00/share with adjustments), and cash-flow burden (monthly payments based on prior-month gross revenue starting March 2027).

02

Market read

A new secured convertible financing with revenue-linked payments and a fixed conversion price is a direct catalyst for HYEX’s balance-sheet and dilution outlook.

03

What to watch

Key sensitivities are the actual gross revenue base used for the 12.5% monthly payment and how quickly conversion becomes likely relative to the company’s path to a Nasdaq/NYSE listing trigger.

Relevance 7/10Novelty 6/10Timing: immediate read-through after the Nov 10, 2026 note signing and Nov 16, 2026 8-K filing

Background

The filing describes a secured convertible promissory note and a related security agreement pledging substantially all assets, with termination tied to an initial listing on major US exchanges.

Company-level read

Ticker impact

$HYEXBearishMedium confidence
Context

Healthy Extracts issued a $555,556 secured convertible note with 13% interest and monthly revenue-linked payments, pledging substantially all assets.

Expected impact

Likely downside pressure as investors price higher leverage and dilution risk, partially offset by cash runway from the note.

Evidence & confidence

The article discloses the note size, interest rate, revenue-linked payment structure starting March 2027, conversion price, and substantially-all-assets collateral, all of which affect credit and equity risk.

Market effects

Adds to the broader pattern of small-cap biotech/healthcare issuers using secured convertibles with revenue-linked payments, which can weigh on peer credit spreads and equity risk appetite.

Limited spillover beyond US micro/small-cap financing sentiment.

Minimal, as the disclosure is company-specific and not tied to global macro or cross-border markets.

Counterpoint

The secured convertible provides defined financing and may reduce immediate liquidity stress, which can stabilize the stock if investors focus on runway rather than dilution.

Key entities

  • Healthy Extracts Inc.

    Company that issued the secured convertible note and pledged substantially all assets to secure it.

  • Hinterland Partners

    Investor/holder providing the $555,556 secured convertible note financing.

Related articles

$ITGRMed

Integer noteholders receive conversion terms following merger

Integer Holdings Corporation completed its merger with Armstrong Bidco Inc., triggering conversion rights for holders of its 2.125% Convertible Senior Notes due 2028 and 1.875% Convertible Senior Notes due 2030. Noteholders can convert their securities until January 8, 2027, receiving enhanced rates during the make-whole period. The company is not required to repurchase the notes due to the merger's cash-only nature.

$CNTYMed

Century Casinos, Inc. Announces Restatement of Previously Issued Financial Statements and Preliminary Third Quarter 2026 Financial Results

Century Casinos (CNTY) will restate financial statements due to accounting errors related to a minority interest in the Nugget Casino Resort. Preliminary Q3 2026 results show $60.2M in cash, $158.4M in revenue, and $20.7M in earnings. The company also announced the sale of its Canadian operations. The restatement may affect internal controls and financial reporting.